All Murdoch Children’s Research Institute articles
-
NewsLast-line antibiotics at risk as children’s resistance rises
Antimicrobial resistance in children is rising globally and will worsen over the next decade, threatening the effectiveness of life‑saving antibiotics, according to a world-first monitoring platform.
-
News COVID-19 booster strategies provide lasting immunity
Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping to reduce costs and improve access to vaccination, according to research. The findings could also inform vaccine dosing and options during future pandemics.
-
NewsNeedle-free flu vaccine aims to boost children’s immunity
A new study will explore the effects of a nasal spray flu vaccine on children’s immune systems, aiming to boost future protection and lower vaccine hesitancy rates.
-
NewsClinical data gaps keeping life-saving antibiotics from children
Antibiotics that could treat severe infections in babies and children aren’t accessible due to a lack of data around safety and dosage. Of 12 antibiotics recommended for serious bloodstream infections caused by a harmful, Gram-negative bacteria, only six were licensed in children aged under 12 and just three in babies.
-
NewsEarlier measles vaccine could help curb global outbreak
The global measles outbreak must trigger an urgent debate into whether a vaccine should be recommended earlier to better protect against the highly contagious disease during infancy, a new review states.
-
NewsNew discovery and grant to accelerate Strep A vaccine efforts
With a large sum of research funding and multinational contributions, the world’s only Strep A human challenge model will be used to resolve logistical issues and speed up the development of a successful Strep A vaccine.
-
NewsCommon viruses trigger most cases of intussusception in children
Viral infections trigger more cases of intussusception, the common cause of bowel blockages in young children, than previously thought, according to a new study.
-
NewsBCG vaccine found ineffective against COVID-19 in healthcare workers
An international trial investigating the potential immune-boosting effects of the tuberculosis BCG vaccine against COVID-19 found that the risk of developing the disease during the first six months after vaccination was not reduced in participants as originally hoped for.
-
NewsBCG does not protect health workers against Covid
A world-leading international trial into the immune boosting benefits of the tuberculosis vaccine, BCG, has found it does not protect healthcare workers against COVID-19.